Induced Pluripotent Stem Cells

Empowering the Development of Next-generation Advanced Models for Drug Discovery by Utilizing iPSC Technology


We specialize in providing biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to bolster drug discovery efforts. As experts in the realm of human induced pluripotent stem cell (iPSC) products and services, we are dedicated to advancing the development of more physiologically relevant in vitro models for the creation of safer and more effective therapies. Our iPSC capabilities facilitate the creation of advanced in vitro disease models and supply the necessary volume for cutting-edge platforms. Whether it's developing simple monoculture models or intricate co-culture, we remain at the forefront of harnessing the potential of iPSCs to drive innovation in research and drug discovery

No items found.

Applications of YBL’s Biospecimens

Enhancing annotation of biological and clinical data and advancing precision medicine

Contact Us

Discovering New Cancer Biomarkers in Human Serum and Plasma

Obtaining Germline DNA, RNA, Proteins & Other Metabolites

High-throughput Drug Screening

Crucial Source to Generate Induced Pluripotent Stem Cells

Develop Patient Specific Models for Personalized Treatment

Generate Patient-derived Tumor Organoids and Xenografts for Therapeutic Efficacy Testing

Accurately Replicate the Growth, Progression, and Metastatic Potential of Tumors